United States Government Publishing Office publisher pbl distributor dst United States Congress author aut Government Organization text government publication eng COMPS Bills and Statutes legislative 2021-10-15 U.S. Government Publishing Office 2015-11-25 continuing Completely irregular deposited born digital 6 p. Y 1.2: https://www.govinfo.gov/app/details/COMPS-11760 P0b002ee1a5a3508c DGPO 2020-02-10 2021-10-15 COMPS-11760 machine generated eng fdlp COMPS COMPS-11760 11760 Improving Regulatory Transparency for New Medical Therapies Act Improving Regulatory Transparency for New Medical Therapies Act Y 1.2: United States Congress associated name asn https://www.govinfo.gov/content/pkg/COMPS-11760 https://www.govinfo.gov/app/details/COMPS-11760 https://www.govinfo.gov/content/pkg/COMPS-11760/pdf/COMPS-11760.pdf https://www.govinfo.gov/content/pkg/COMPS-11760/uslm/COMPS-11760.xml To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.;Improving Regulatory Transparency for New Medical Therapies Act;Improving Regulatory Transparency for New Medical Therapies Act; COMPS COMPS-11760 11760 Improving Regulatory Transparency for New Medical Therapies Act Improving Regulatory Transparency for New Medical Therapies Act Public Law 114-89